Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 9NETWORK 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 5CNS 3Breast 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Breast Neoplasms 265Breast Neoplasms, Male 20Breast Carcinoma In Situ 15Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 12Carcinoma, Intraductal, Noninfiltrating 12Neoplasm Metastasis 11Lung Neoplasms 11Carcinoma, Ductal, Breast 11Pain 9Colorectal Neoplasms 9Colonic Neoplasms 9Neoplasms 8Inflammatory Breast Neoplasms 8Osteoporosis 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Ovarian Neoplasms 6Fatigue 6Small Cell Lung Carcinoma 5Rectal Neoplasms 5Testicular Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Multiple Myeloma 4Melanoma 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neurotoxicity Syndromes × Breast × Clear all
NCT00775645 2017-08-14

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

SWOG Cancer Research Network

Phase 3 Completed
437 enrolled 14 charts
Breast

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

NCT01763710 2016-03-29

neurabrax

Fundacion Oncosur

Phase 2 Completed
60 enrolled
Breast

Breast Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡